Release Date: 11/02/14 12:57 Summary: Interim Financial Report 31 December 2013 Price Sensitive: No Download Document 398.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%